The Veet hair removal system for hairy gorillas is flying off the shelf.

This surely has to be a buy? DYOR

http://www.reckittbenckiser.com/

Half year report: http://www.moneyam.com/action/news/showArticle?id=5597368

Reckitt Benckiser endured a "soft" third quarter amid a continued challenging market and has downgraded its full year guidance. With like-for-like net revenue down -1% in the year to date, the base RB business is now expected to be flat for the full year, while guidance for newly acquired Mead Johnson was kept at '-2% to flat'.

Q1 2018 Trading Update

Highlights: Q1 (at constant rates)

· Proforma growth of +3% (+2% LFL). Proforma and LFL growth were both volume-led (+3%).

· RB 2.0: good progress in both business units.

· Health performance +3% proforma (+1% LFL) against a backdrop of strong trends in IFCN growth and seasonal tailwinds in the US. Strong performances in Gaviscon, Mucinex, Strepsils and VMS brands but significant underperformance in Scholl. Middle East macro issues impacting Dettol.

· Mead Johnson Nutrition (MJN) performance continues to progress well with proforma growth +6% for Q1. Strong market growth in Greater China, and sell in of Enfamil Neuro Pro innovation in the US reinforces the strong fundamentals of this category.

· Hygiene Home had a strong start to the year at +4% LFL driven by a combination of improved in-market execution, seasonal benefit to Lysol in the US and sell in of our new innovations in Finish and Air Wick.

· On track for our full year net revenue target of +13-14% (total constant), implying +2%-3% LFL*.

more.....

Q3 2018: Trading Update

Highlights

· LFL growth in Q3 of +2%. Continued momentum under RB 2.0, with growth in base Health and Hygiene Home businesses of +4% LFL. Total growth was negatively impacted by -2% (£70m) from a temporary manufacturing disruption at our European IFCN plant.

· LFL performance in Total Health was flat, comprising IFCN of -6% and Rest of Health of +4% driven by continued strong growth in OTC and improving trends in Wellness and Health Hygiene brands.

· LFL growth in Hygiene Home of +4%. Continued momentum with strong performances from Finish, Air Wick and Lysol in ENA and Harpic in DvM.

· We remain on track for the full year net revenue target of +14-15% (total constant), implying LFL revenue growth at the upper end of +2-3%.

more.....

Liberum Capital Buy 6271.00 7600.00 Reiterates

Reckitt Benckiser Group announced on Wednesday that Rakesh Kapoor had indicated his intention to retire as chief executive officer by the end of 2019. The FTSE 100 company said he would have served more than eight years as CEO, and 32 years at the firm, by the time he steps down. Its board confirmed it had initiated a formal process to appoint his successor, considering both internal and external candidates.